-
Study aim
-
The effect of TheraCal-LC® and Mineral Trioxide Aggregate in pulpotomy of primary molars will be comprised with the aim of preservation of tooth vitality and structure and prevention of more aggressive treatments.
-
Design
-
In this randomized, single blind, split mouth,controlled clinical trial study with parallel group, symmetrical bilateral primary molar teeth in maxilla or mandible will be chosen in 45 patients (overall 90 teeth).Randomization will be done by throwing a coin.
-
Settings and conduct
-
This clinical trial study will be done in Tabriz dentistry faculty. After obtaining informed consent from parient's parents,local anesthesia injection, isolation, and caries excavation, in group A, TheraCal-LC® placement and in group B, MTA placement in exposure site will be performed. In this single blind study, participants are unaware of the allocation of study groups and information is not given to the parents about which of the materials is used in the patient's left or right primary molar.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: 5 to 8 years old children having a pair of symmetric primary molar teeth in one jaw having deep caries and vital pulp and no history of spontaneous pain; No sign of radiolucency or pathologic root resorption Exclusion criteria:Lack of informed consent by the child patient’s parent; Abnormal bleeding at the site of pulp exposure.
-
Intervention groups
-
Local anesthesia injection, isolation, and caries excavation and access cavity will be performed in both groups and in group A, TheraCal-LC® placement and in group B, MTA placement in exposure site will be performed. Then in both groups the site will be covered with Glass Ionomer. After amalgam restoration, periapical radiographs will be obtained.
-
Main outcome variables
-
Clinical success(Dental pulp vitality after treatment); Radiographic success.